<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-578
Date of Submission: 2024-09-25

This report was submitted by a Nurse from Chapman, Hunt and Fisher Medical Center concerning patient ANON-PX-6811. The subject is a 89-year-old other with a significant medical history including migraines, coronary artery disease, type 2 diabetes, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril (ACE inhibitor) administered via the Intravenous route at a dosage of 34mg, initiated on 2024-08-09 for Hypertension and discontinued on 2024-09-04.

On approximately 2024-08-26, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Maculopapular Rash. The Stevens-Johnson syndrome was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed something and advised stuff. The current patient status regarding this symptom is 'Unknown'. The Maculopapular Rash was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 2 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Hand range and possible. Recent deal doctor evidence. Occur owner international life indeed short.</data>
report_id: ADR-2024-578
report_date: '2024-09-25'
patient_details:
  patient_id: ANON-PX-6811
  gender: Other
  relevant_history:
  - migraines
  - coronary artery disease
  - type 2 diabetes
  - seasonal allergies
  age_at_reaction: 89
suspected_drugs:
- drug_name: Lisinopril
  dosage: 34mg
  route_of_administration: Intravenous
  start_date: '2024-08-09'
  indication_for_use: Hypertension
  drug_class: ACE inhibitor
  end_date: '2024-09-04'
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2024-08-26'
  severity: Mild
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed something and advised stuff.
- symptom_name: Maculopapular Rash
  onset_date: '2024-08-26'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 2
reporting_facility: Chapman, Hunt and Fisher Medical Center
reporter_type: Nurse
notes: Hand range and possible. Recent deal doctor evidence. Occur owner international
  life indeed short.
